Bridging pharmacology and neurodevelopment in schizophrenia.
Kato
Tadafumi
T
Laboratory for Molecular Dynamics of Mental Disorders, RIKEN Brain Science Institute, Hirosawa 2-1 Wako 351-0198, Japan. kato@brain.riken.jp
D014150:Antipsychotic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D011600:Psychopharmacology; D012559:Schizophrenia / Q000139:chemically induced / Q000188:drug therapy* / Q000235:genetics; D012565:Schizophrenic Psychology; D012694:Serine / Q000502:physiology
D014150:Antipsychotic Agents; D012694:Serine